Tag: "penn" at medical news

Openness is key to winning the war over MMR

Openness and communication between experts and the public is key to winning the war over MMR, says an expert in this week's BMJ....... In 1998, MMR vaccinations in the United Kingdom reached 92% of its targets. Yet by 2002, after claims of a possible relation between MMR and autism, the United Kingdom lost considerable ground. One of the lowest levels of coverage of MMR is now found in London, at...

Penn study will compare heart failure management technologies

(Philadelphia, PA) Researchers at the Hospital of the University of Pennsylvania (HUP) have been awarded a $1.5 million dollar grant from the Agency for Health Care Research and Quality and the National Institutes of Health to study disease management technologies in patients with heart failure, and patients with both heart failure and diabetes. The principal investigator for the two-site trial...

Pennsylvania chemist wins national award for pharmaceutical research

Xumu Zhang of University Park, Penn., will be honored August 20 by the world's largest scientific society for developing tools to tailor-make drug molecules. He will receive the 2002 Arthur C. Cope Scholar Award from the American Chemical Society at its national meeting in Boston....... "Our particular research field is related to ways of making modern-day medicines," said Zhang, an organic chemi...

U Penn researchers combating blindness from diabetic retionopathy in local community with 4 Sight program

.(Philadelphia, PA)--The Scheie Eye Institute, in conjunction with the University of Pennsylvania Health System, continues to expand an aggressive and unique recruitment program within the local West Philadelphia community to promote the early detection of diabetic retinopathy. While ophthalmologists have a treatment that is nearly 100 % effective in preventing this form of blindness, it remain...

Penn Researchers Initiate Ground-Breaking New Trials To Treat

(Philadelphia, PA) -- Surgeons and radiation oncologists at the...University of Pennsylvania Medical Center have recently initiated...ground-breaking new protocols to treat locally advanced cases of...lung cancer and mesothelioma for patients who are generally...considered untreatable at other institutions. These new clinical...trials are applying innovative combination treatments with...photod...

PENN begins clinical trial of newest technology to treat thoracic aortic aneurysms

(Philadelphia, PA) A clinical trial is underway at the Hospital of the University of Pennsylvania (HUP) to study the safety and effectiveness of an endovascular medical device to treat life-threatening thoracic aortic aneurysms. Ronald Fairman, MD, Chief of Vascular Surgery at HUP, is leading the study at Penn and is one of 35 principal investigators in North America to participate in this land...

Penn joins major NCI research initiative to advance breast cancer therapies

(Philadelphia, PA) - The University of Pennsylvania School of Medicine was recently selected to become a member of the National Cancer Institute's Mouse Models of Human Cancers Consortium (MMHCC). The MMHCC was established in 1999 to design and characterize mouse models that more accurately reflect the way that human cancers develop and respond to therapy. The research groups comprising the MMHCC...

Penn study shows how next-generation diabetic drugs could work more selectively

(Philadelphia, PA) In an attempt to find a new generation of diabetic drugs that will minimize side effects, researchers at the University of Pennsylvania School of Medicine report a new understanding of how thiazolidinediones (TZDs), widely used diabetic medications, work in fat cells. With yearly sales exceeding billions of dollars, TZDs such as rosiglitazone maleate (Avandia) and pioglitazon...

PENN study emphasizes need for national guidelines for assisted reproductive technology programs

(Philadelphia, PA) - Infertility prevents roughly 6.1 million people in the United States from having children. As a result, infertile individuals and couples commonly seek to become parents through assisted reproductive technology (ART). Since 1981, approximately 177,000 babies have been born via ART: and, in one year alone (2000), some 100,000 cycles of ART were attempted, resulting in 60,253 l...

Penn researchers add more evidence to demonstrate role of COX inhibitors in heart-disease risk

(Philadelphia, PA) In two articles, published in Circulation, researchers from the University of Pennsylvania School of Medicine provide further evidence for the role of cyclooxygenases (COX) in heart-disease risk. In one, a statistical meta-analysis of two placebo-controlled trials, the COX-2 inhibitor Bextra elevated the combined incidence of heart attack and stroke three-fold in coronary arte...

Penn study may lead the way for first medication to treat cocaine addiction

(Philadelphia, PA) Cocaine dependence is a major public health problem affecting thousands of people around the globe. Despite years of active research there are still no approved medications for the treatment of this life-shattering addiction. Researchers are now hopeful that may soon change based on the results of a controlled study done at the University of Pennsylvania School of Medicine....

Penn professor earns 2004 award from the American College of Psychiatrists

(Philadelphia, PA) -- Dwight L. Evans, MD, the Ruth Meltzer Professor and Chairman of the Department of Psychiatry at the University of Pennsylvania School of Medicine, has earned the 2004 Award for Research in Mood Disorders from the American College of Psychiatrists. This award which honors an individual or individual whose group has made major contributions to the understanding and treatment...

Penn epidemiological study shows difference in cardiovascular effects between Vioxx and Celebrex

(Philadelphia, PA) -- In the first epidemiological study designed and executed specifically to determine the heart-attack risk associated with COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex), researchers at the University of Pennsylvania School of Medicine found a greater risk of heart attack associated with Vioxx than Celebrex, although neither of the two drugs showed a statistically...

Penn addictions expert, Charles P. O'Brien, MD, PhD, receives prestigious, international honor

(Philadelphia, PA) Charles P. O'Brien, MD, PhD, Vice Chair, Department of Psychiatry and Director, Center for the Study of Addictions at the University of Pennsylvania School of Medicine and Director of Psychiatric Research at the Philadelphia Veteran's Administration Medical Center (VAMC), has been invited by the Academisch Medisch Centrum (Academic Medical Center) and the University of Amsterd...

University of Pennsylvania Health System launches life-saving eICU technology

(Philadelphia, PA) The University of Pennsylvania Health System (UPHS) will be the first health system in the tri-state area (Pennsylvania, New Jersey and Delaware) to go live with eICU technology on November 15th. The Health System's Penn E-lert will permit remote "live" coverage of Intensive Care Units (ICUs) by practicing, critical-care physicians intensivists via a comprehensive telemedic...

The Gerontological Society of America confers 2004 M. Powell Lawton Award to Penn State's Zarit

The Gerontological Society of America has chosen Penn State University's Dr. Steven Zarit to receive its 2004 M. Powell Lawton Award. The distinction recognizes a significant contribution in gerontology that has led to an innovation in gerontological treatment, practice or service, prevention, amelioration of symptoms or barriers, or a public policy change that has led to some practical applicati...

The Hospital of the University of Pennsylvania evaluates heart failure treatments for landmark study

(Philadelphia, PA)-"Heart failure is a leading cause of death and nearly 5 million people in the United States suffer from it," says Mariell Jessup, MD, Professor of Medicine and Medical Director of the Heart Failure and Transplantation Program at the Hospital of the University of Pennsylvania (HUP). Jessup, along with David Callans, MD, Professor of Medicine and Director of the Electrophysiolog...

Smoking cessation study at Penn open to volunteers

(Philadelphia, PA) Researchers at the Abramson Cancer Center of the University of Pennsylvania are looking for volunteers to compare the effectiveness of two leading, FDA-approved smoking cessation medications in combination with different types of counseling. The study led by clinical social worker Peter Gariti, PhD is the world's first head-to-head trial of the two medications for light smo...

A penny a month could bolster kids' immunization practices

Researchers from the University of California at San Diego, writing in the January issue of the American Journal of Preventive Medicine, calculate that $0.013 per child per month is needed to make recommended innovations such as patient education and feedback to doctors a regular part of immunization practice....... "Public health officials, policymakers, insurers and healthcare entities must mak...

New project will develop cancer maps for Pennsylvania

A three-year, $736,000 grant from the Association of American Medical Colleges and Centers for Disease Control and Prevention (CDC) will allow Penn State Cancer Institute to develop cancer maps to identify Pennsylvania communities with particularly high rates of colorectal and prostate cancer. ... "A picture, or a map in this case, is worth a thousand words," said Eugene Lengerich, V.M.D., M.S.,...

New stent graft for thoracic aneurysms offered at Penn

In an important step toward further establishing treatment options for patients with life-threatening aneurysms or trauma involving the aorta, the body's largest artery, the University of Pennsylvania Medical Center is participating in an FDA-approved clinical trial of the TalentTM Thoracic Stent Graft System, manufactured by Medtronics, Inc. ...Ronald M. Fairman, MD, Chief of Penn's Division of...

New Penn study shows genes may influence smoking cessation

(Philadelphia, PA) - Smokers with a specific combination of two genetic variants may be more likely to remain abstinent and less prone to relapse when trying to quit smoking, a study by researchers from the Tobacco Use Research Center of the University of Pennsylvania School of Medicine indicates. This research which will appear in the October issue of Health Psychology- has important implicati...

Penn study to determine why African-American males have worse outcomes from prostate cancer

(Philadelphia, PA) Compared with Caucasian, Asian, or Hispanic men, African-American men have the highest incidence of prostate cancer in the world, are stricken at a younger age and, once diagnosed, are more likely to suffer bad outcomes from the disease including death, impotence and incontinence. ...To understand why African Americans have poorer outcomes when they are diagnosed with prosta...

Clinical study of Penn State Hershey technology begins in South Africa

The first clinical study of the neonatal chest wall stabilizer developed at Penn State Hershey Medical Center recently began at three hospitals in Johannesburg, South Africa. ... Charles Palmer, M.B., Ch.B., device inventor and professor of pediatrics, Penn State College of Medicine, spent two weeks in August in South Africa where he trained medical staff to use the chest wall stabilizer, a devic...

Penn State to host national symposium on fertility decline in developed countries

In most highly developed countries more and more women are choosing to have fewer or no children, to delay childbearing (often until the chances of having a viable pregnancy are greatly reduced), and to have children outside of marriage. Overall, adults appear to be less interested in investing in children now than in the past. ... Family scholars from across the nation will converge on Penn St...

Penn study: Herb product used to lower cholesterol works no better than placebo

A natural extract often favored by health-conscious Americans as an alternative to manufactured drugs in lowering cholesterol has turned out to be no more effective than a placebo in clinical trials at the University of Pennsylvania School of Medicine....The Penn research findings on the guggulipid extract will be published in the August 13 issue of the Journal of the American Medical Association...

Distortion and lack of openness - Information provision from the pharmaceutical industry

Authors of an article in this week's issue of THE LANCET-the first of a series of four articles assessing the role of the pharmaceutical industry in medicine-are critical of the way in which multinational pharmaceutical companies manipulate the provision of information, and say that this contributes to a distortion of medical research. ...... Joe Collier and Ike Iheanacho from Drug and Therape...

Penn State College of Medicine awarded $6.9 million to create clearer images of body's interior

Clearer images of the body's interior may allow physicians to get to the bottom of their patients' medical problems faster. ... A $6.9 million grant from the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering will allow a team of researchers led by Michael B. Smith, Ph.D., professor of radiology, Penn State College of Medicine, to study ultra high fiel...

Penn finds atrial fibrilation cure eliminates need for pacemakers, medicine

Cardiac Rhythm Specialists for the University of Pennsylvania Health System have documented the effectiveness of a new technique to cure atrial fibrillation (A-Fib). The technique targets and isolates the triggers, or "hot spots," on pulmonary veins leading to the heart, preserving the heart's natural electrical circuitry and eliminating the need for a pacemaker or medication.... Francis E....

Reducing the risk of medication errors: Announcing the Penn Center for Patient Safety Research and Practice

(Philadelphia, PA) The University of Pennsylvania Medical Center has assembled a multidisciplinary team of physicians and researchers to form the Center of Excellence for Patient Safety Research and Practice. A $7 million grant from the Agency for Healthcare Research and Quality (AHRQ) will fund the center through its first five years of operation. The centers mission will be to examine medicati...

Submicrometer-scale metallic barcodes described by Penn State and Surromed

Researchers at Penn State University and SurroMed, Inc., in the 5 October issue of the journal Science report on the fabrication, optical properties, and initial application of microscopic metallic barcodes. When coated with biomolecules, these patterned metallic particles enable the simultaneous monitoring of multiple biological reactions in very small volumes of fluid. ...... The researchers...

Penn Engineering's David Meaney wins Y.C. Fung Award, a top honor for young bioengineering researchers

PHILADELPHIA David F. Meaney, a bioengineer at the University of Pennsylvania, has been named the 2001 recipient of the Y.C. Fung Young Investigator Award, one of his fields top honors for young researchers.... ...The Fung Award goes to a bioengineering researcher younger than 36 who demonstrates the potential to make substantial contributions to the discipline. It has been awarded annually by...

Penn researchers: Protein may be the essential piece to the pathway by which insulin controls blood sugar

.(Philadelphia, PA) Researchers have mimicked the effects of insulin resistance of human type 2 diabetes by creating mice that lack a functional gene for the enzyme Akt2. According to Morris J. Birnbaum, MD, PhD, of the University of Pennsylvania School of Medicine and Howard Hughes Medical Institute, the experiment establishes Akt2, a signaling enzyme also found in humans, as essential for ma...

UPenn Cancer Center receives two-year $500,000 grant from Lance Armstrong Foundation to establish cancer survivorship program

.PHILADELPHIA, PA - The University of Pennsylvania Cancer Center today announced receiving a two-year $500,000 grant from the Lance Armstrong Foundation (LAF). The grant will be used to develop a new model of care for long-term survivors of cancer. . .The goal of the University of Pennsylvania Cancer Center survivorship program, called Living Well After Cancer, is to help reduce the physical an...

Penn researchers identify new cost-effective antibiotic treatment which shortens patient stays

.(Philadelphia, PA) - University of Pennsylvania Health System researchers and their colleagues have concluded that the antibiotic linezolid has the potential to provide hospitals cost-saving benefits, when used to treat infections resistant to most other antibiotics that can extend patients length of stay. The drug is the first in a new class of antibiotics that attack bacteria in a way unlike...

Penns Head Injury Center receives $110,000 NFL charities grant to study long-term effects of concussions

. Knocking heads is part of the rough and tumble action of a football game, but few things can sideline an otherwise healthy athlete faster than a concussion. To study the long-term effects of concussions, NFL Charities, an organization of the member clubs of the National Football League, has awarded a $110, 000 grant to the Head Injury Center (HIC) of the University of Pennsylvania Medical C...

Penn chemist Ralph F. Hirschmann among 12 scientists selected to receive the 2000 National Medal of Science

.PHILADELPHIA -- President Bill Clinton announced today that University of Pennsylvania chemist Ralph F. Hirschmann, Ph.D., is among 12 recipients of the 2000 National Medal of Science. Hirschmann and his fellow honorees will receive their medals at a White House dinner Dec. 1.. .Hirschmann, the Rao Makineni Professor of Bioorganic Chemistry, joined Penn in 1987 after retiring as Mercks senior...

Gender bias in salaries among Pennsylvania M.D.'s, find University of Pittsburgh researchers

. PITTSBURGH, July 17 -- Female physicians in Pennsylvania earn significantly less money than their male counterparts, report investigators from the University of Pittsburgh's Graduate School of Public Health (GSPH) in the July 18 issue of the Annals of Internal Medicine. After adjusting for demographics, training and practice characteristics, investigators found that among internal medici...

Penn researchers announce results of Phase I trial using combretastatin drug

. . . . . . (Philadelphia, PA) -- New approaches are needed to treat solid malignant tumors that cannot be removed surgically and are resistant to traditional powerful chemotherapy drugs. In a Phase I clinical trial, a team of researchers at the University of Pennsylvania Cancer Center has found that patients with solid cancerous tumors were able to safely tolerate a ne...

U.S., Mexican scientific societies honor former Penn State professor

... ... ............Chemistry societies in the U.S. and Mexico join forces this month to honor a...former Penn State professor for his landmark work to develop a cheaper way to...mass produce the hormone progesterone. The work later led to the wide...availability of such products as oral contraceptives and cortisone, a treatment...for rheumatoid arthritis.... ...The American Chemical Society an...
(Date:4/17/2014)... University School of Medicine (BUSM) have discovered that ... an experimental model. The findings, reported in the ... , may lead to more effective treatments for ... of the leading causes of illness and death ... impact by limiting the productivity of workers and ...
(Date:4/17/2014)... has the potential to ward off depression among retirees, ... published online in The Journals of Gerontology, ... In the article " Internet Use and Depression Among ... Analysis ," the authors report that Internet use reduced ... among their study sample. , Late-life depression affects ...
(Date:4/17/2014)... ribbon representing a disease. A pink ribbon is well known ... think of with lung cancer?, Although white has been identified ... black may be the only one they think fits., A ... smokers between the ages of 51 to 79 years old, ... these patients, the emotional toll it can have and how ...
(Date:4/17/2014)... is less than 40 years away from a food ... governments, according to a top scientist at the U.S. ... human history, food production will be limited on a ... energy," said Dr. Fred Davies, senior science advisor for ... become as politically destabilizing by 2050 as energy issues ...
(Date:4/17/2014)... TORONTO, April 17, 2014 Giving patients adrenaline after they ... not increase their prospects of surviving long-term, according to ... vast number of patients who have a cardiac arrest ... treating cardiac arrest for decades," said Dr. Steve Lin, ... Michael,s. "Yet, despite advances in medical treatment, long-term survival ...
Breaking Medicine News(10 mins):Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Internet use may cut retirees' depression 2Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Food shortages could be most critical world issue by mid-century 2Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2
Other Tags
subtypekrausspricesderegulationhazardsairbagelevatinghourssometimesstirredunacceptablestoppedbrochurespromotionalpairsambiguous